Advertisement
Research Article Free access | 10.1172/JCI113641
Department of Orthopaedics, Mount Sinai School of Medicine, New York 10029.
Find articles by Suárez, G. in: JCI | PubMed | Google Scholar
Department of Orthopaedics, Mount Sinai School of Medicine, New York 10029.
Find articles by Rajaram, R. in: JCI | PubMed | Google Scholar
Department of Orthopaedics, Mount Sinai School of Medicine, New York 10029.
Find articles by Bhuyan, K. in: JCI | PubMed | Google Scholar
Department of Orthopaedics, Mount Sinai School of Medicine, New York 10029.
Find articles by Oronsky, A. in: JCI | PubMed | Google Scholar
Department of Orthopaedics, Mount Sinai School of Medicine, New York 10029.
Find articles by Goidl, J. in: JCI | PubMed | Google Scholar
Published August 1, 1988 - More info
As a consequence of an increased flux through the sorbitol pathway fructose levels rise in various tissues in diabetes. Also, in vitro nonenzymatic fructosylation of protein induces the generation of fluorescence at a rate 10 times greater than glucosylation. The administration of sorbinil, an aldose reductase inhibitor known to lower tissue fructose concentration, to experimental diabetic rats led to a decrease in the fluorescence related to advanced Maillard products in their skin collagen. This effect is consistent with the in vivo occurrence of nonenzymatic fructosylation of collagen. A potential pathogenetic role for this posttranslational modification in diabetic complications should be considered.
Click on an image below to see the page. View PDF of the complete article